Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients Academic Article uri icon

Overview

MeSH Major

  • Antifungal Agents
  • Hematopoietic Stem Cell Transplantation
  • Mycoses
  • Pyrimidines
  • Triazoles

abstract

  • Future voriconazole studies should incorporate prospective therapeutic drug monitoring and consideration should be given to checking levels in patients receiving the drug for confirmed, life-threatening fungal infections.

publication date

  • April 15, 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.22568

PubMed ID

  • 17351937

Additional Document Info

start page

  • 1532

end page

  • 5

volume

  • 109

number

  • 8